Company profile
Catheter Precision, Inc.
AMEX: VTAK · Healthcare · Medical - Devices
#885 of 1,418 Healthcare companies by revenuetop-quartile growth
EA Score
39DFH 30DQ 43GM 63SS 34
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, revenue growth (YoY) · ↓ growth stability, return on equity
Methodology →Revenue TTM
$1.1M
Rev growth YoY (TTM)
+130.4%
Net income (FY)
-$17.2M
Employees
17
as of 2026-08-26
Market cap
$565.7k
as of 2026-08-26
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$819.0k$819.0k2025
Net income-$17.2M-$17.2M2025
Operating income-$21.1M-$21.1M2025
Total assets$15.9M$15.9M2025
Liabilities$9.2M$9.2M2025
Equity$7.1M$7.1M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY24
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product100%
By geography
UNITED STATES80%
Europe20%
The read
What is Catheter Precision, Inc.’s revenue?
Catheter Precision, Inc. booked $819.0k in FY2025 revenue, growing 95% year over year — faster than most Healthcare companies we track, at a -2098.0% net margin.
Peers · Healthcare
Universal Ibogaine Inc.——Advantis Corp.——Imagenetix, Inc.——Onconetix, Inc.25DHyperion DeFi, Inc.35DHelix BioMedix, Inc.56CNeighbors
York →Key facts
CEODavid A. Jenkins
SectorHealthcare
IndustryMedical - Devices
HeadquartersFort Mill, SC
ExchangeAMEX: VTAK
Employees17
IPO date2018-09-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.